Online Only Articles

GRP94 rewires and buffers the FLT3-ITD signaling network and promotes survival of acute myeloid leukemic stem cells

Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Montebello;Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, Montebello
Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Montebello;Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, Montebello
Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Montebello;Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, Montebello;Institute of Clinical Medicine, University of Oslo
Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Montebello;Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, Montebello;Department of Hematology, Oslo University Hospital, Rikshospitalet, Oslo
Centre for Cancer Biomarkers, Department of Clinical Science, University of Bergen
Centre for Cancer Biomarkers, Department of Clinical Science, University of Bergen
Centre for Cancer Biomarkers, Department of Clinical Science, University of Bergen
Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Montebello;Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, Montebello;Institute of Clinical Medicine, University of Oslo
Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Montebello
Norwegian National Unit for Newborn Screening, Woman and Children’s Division, Oslo University Hospital, Rikshospitalet
Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Montebello;Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, Montebello
Department of Hematology, Oslo University Hospital, Rikshospitalet, Oslo;Hematology Section, Department of Internal Medicine, Haukeland University Hospital, Bergen
Department of Hematology, Oslo University Hospital, Rikshospitalet, Oslo;Hematology Section, Department of Internal Medicine, Haukeland University Hospital, Bergen
Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Montebello;Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, Montebello;Section for Biochemistry and Molecular Biology, The Department of Biosciences, Faculty of Mathematics and Natural Sciences, University of Oslo, Norway
Vol. 104 No. 5 (2019): May, 2019 https://doi.org/10.3324/haematol.2019.220533